International Clinical Trial: A Multicenter, Randomized, Investigator single-blinded, Open label, Phase 4 Trial to Evaluate the Efficacy and Safety of Cyporin-N(cyclosporine) and Rebamipide Ophthalmic Drops in Patients with Dry Eye Syndrome (CyReN Study)

Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (KCT0011522) titled 'A Multicenter, Randomized, Investigator single-blinded, Open label, Phase 4 Trial to Evaluate the Efficacy and Safety of Cyporin-N(cyclosporine) and Rebamipide Ophthalmic Drops in Patients with Dry Eye Syndrome (CyReN Study)' on Jan. 22.

Study Type: Interventional Study

Study Design: Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Single, Blinding Target : Investigator, Allocation : RCT

Primary Sponsor: Gyeongsang National University Hospital

Condition:

Diseases of the eye and adnexa

Intervention: Drug : Experimental group: Cyclosporine 0.5 mg/mL ophthalmic solution will be instill...